The new consumer healthcare company will be based at a newly built campus in Weybridge
News
AZ’s long-acting antibody combo shows benefit in COVID-19 trial
AZD7442 cut the risk of severe COVID-19 and death by 50% in outpatients
UK pharmacy M&A transactions up by 26%
Pharmacies saw increased customer demand during the pandemic, says UHY Hacker Young
COVID-19 vaccine trial participants to be offered additional doses
‘Top-up’ doses of approved vaccines to be offered to ensure clinical trialists can travel abroad
Medtech firm Entia raises $12m for ‘virtual oncology solution’
Virtual monitoring service enable patients to perform their own at-home blood tests
NICE backs Rinvoq for moderate active RA
Decision expands access to oral therapy to around 27,000 people in England
Poolbeg Pharma launches AI programme with Eurofins Genomics
London-based infectious disease pharmaceutical company, Poolbeg Pharma, has announced their deal with testing and support specialist, Eurofins Genomics, according to Proactive Investors.
Fungus-derived cancer killing drug by Oxford University shows promise
A chemotherapy drug, NUC-7738, which is derived from a Himalayan fungus has been found to have 40 times greater potency in killing cancer cells than its original parent compound.
Alnylam becomes new partner in the Medicines Manufacturing Innovation Centre
Leading RNA intereference (RNAi) therapeutics company, Alnylam, has been welcomed as the latest partner in the Medicines Manufacturing Innovation Centre, to transform the manufacturing process of oligonucleotide therapies.
AstraZeneca pursues approval for COVID-19 antibody cocktail
AstraZeneca has submitted an emergency approval to the US drug regulators for its COVID-19 antibody cocktail, which would be the first non-vaccine protection from the virus to be granted approval.
UK’s first ‘asthma bus’ to support NHS respiratory service
The UK’s first ‘asthma bus’ is set to begin its journey around the country, aiming to offer crucial support to pressured NHS respiratory services, as asthma sufferers have admitted to delaying care during the pandemic to avoid the risk of catching COVID-19.
First subject given COVID-19 vaccine candidate in UK-based Scancell’s COVIDITY trial
UK-based Scancell Holdings has announced that its first subject has been dosed in its COVIDITY clinical trial in South Africa.
CHMP positive option for Pfizer-BioNTech COVID-19 vaccine in the EU
Pfizer and BioNTech have announced that the Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for the administration of the Pfizer-BioNTech COVID-19 vaccine as a booster shot six months after the second dose.
AiPharma forms alliance with Appili Therapeutics
Private biopharmaceutical research, development, and commercialisation company, AiPharma, has announced a strategic alliance with biopharmaceutical company Appili Therapeutics Inc (Appili), to advance the global development of Avigan®/Reeqonus™ (favipiravir).
Largest COVID-19 PCR provider announces expansion of ‘cube’ labs
The UK’s largest laboratory diagnostics company, Randox, has announced a nationwide expansion of ten new adaptive ‘cube’ laboratories across Great Britain, with facilities that provide a rapid and cost-effective model to expand laboratory provision.
